You are here: Home > A Word From Our Experts

Blockbuster Pharmaceutical Launches:
The Road to Future Growth

continued ...

Performance Programs and Execution
Execution is the key to sustainable revenue growth. Develop a person's ability to perform and they will execute. Successful performance development programs are based on outcomes and measurable results. Traditional launch training programs that are event based and focus solely on learning outcomes will not facilitate execution and they will not drive sustainable revenue growth.

Thanks in no small measure to Pfizer's performance development programs; sales of Lipitor soared to $1.9billion only 2 years after its launch. In 2001, Lipitor was reported to be the top-selling drug in the world with record sales of $7.0 billion. Successful launch training programs enable success by challenging people's ability to execute. As a senior vice president at Pfizer recently said regarding the philosophy of Karen Katen, the President of the Pfizer Pharmaceuticals Group and Executive Vice President of Pfizer Inc, "She realizes the importance of developing people and she does that by pushing them--keeping their feet to the fire--and also by providing them with the resources and support to get the job done."

1-2-3-4-5
<< Prev Page <<         >> Next Page >>